¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18
±³À°ÀÏÀÚ : 2020-09-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ºñ¸â¹ö ÀÇ»ç 15¸¸¿ø ¸â¹ö ÀÇ»ç 10¸¸¿ø ºñ¸â¹ö ºñÀÇ»ç 10¸¸¿ø ¸â¹ö ºñÀÇ»ç 5¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:10~09:40 SGLT2 inhibition and kidney protection in people without diabetes  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:40~10:10 Anti-diabetes drugs and proteinuria  Soon Hyo Kwon(Soonchunghyang University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:10~10:40 Anti-diabetes drugs and GFR  Sang Soo Kim(Pusan National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:40~11:10 Multiomics approach in DKD research  Nan Hee Kim(Korea University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ11:30~12:00 Diabetes care: post COVID-19 new normal  Kun-Ho Yoon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:00~12:30 Digital transformation of future medicine accelerated by COVID-19  Sungroh Yoon(Seoul National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:50~13:10 Empagliflozin? potential role in T2D & complications  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:00~14:30 Lack of a legacy effect in patients with diabetes and cardiovascular disease  Neda Laiteerapong(The University of Chicago USA) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:30~15:00 Early intensive combination therapy in T2DM: pros and cons  Chang Hee Jung(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:00~15:30 Strategy to achieve remission of diabetes: life style and metabolic surgery (direct trial (low calorie diet)  Hyuk Sang Kwon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:30~16:00 Do we need to use SGLT2i/GLP-1RA in well-controlled diabetes with increased CV risk?  Roopa Mehta(INCMNSZ Mexico) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:20~16:50 Blood glucose, antidiabetic drugs, and stroke risk  Meng Lee(Chang Gung University Taiwan) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:50~17:20 Hypoglycemia and brain  Ji-Young Kim(Inje University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:20~17:50 Screening and diagnosis of diabetic peripheral arterial disease  Pil Hyung Lee(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:50~18:20 Update of current treatment of diabetic peripheral arterial disease  Su Hong Kim(Busan Veterans Hospital Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¦ 19 ȸ ºÎ»ê°æ³²Áßµ¶¿¬±¸È¸(ASBK) ¼¼¹Ì³ª & Çѱ¹Áßµ¶Á¤½ÅÀÇÇÐȸ ½ÉÆ÷Áö¾ö : 2020-09-18
´ÙÀ½±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦76Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2020) 2ÀÏÂ÷ : 2020-09-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21075 ¼­¿ï 2024³â ´ëÇѼö¸é¿¬±¸ÇÐȸ Á¤±â Çмú´ëȸ DAY 1 : 2024-07-06 0 7 2024-06-18
21074 ±¤ÁÖ 2024³âµµ ´ëÇÑÇǺΰúÀÇ»çȸ ±¤ÀüÁöºÎ ±³À°½ÉÆ÷Áö¿ò : 2024-07-06 0 7 2024-06-18
21073 ¼­¿ï (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 2 : 2024-07-06 0 4 2024-06-18
21072 ´ë±¸ 2024 ´ëÇѺñ¸¸ÇÐȸ Obesity Summer Çмú´ëȸ : 2024-07-06 0 24 2024-06-18
21071 ¼­¿ï 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06 0 9 2024-06-18
21070 ¼­¿ï ´ëÇѺҾÈÀÇÇÐȸ (¿Â¶óÀÎ) ½ºÆ®·¹½º°ü¸® ÇÁ·Î±×·¥ : 2024-07-06 0 14 2024-06-18
21069 ¼­¿ï 2024³â Á¦25ȸ ´ëÇÑÇǺΰúÇÐȸ ¿¬¼ö±³À° : Conerstone and General : 2024-07-06 0 7 2024-06-18
21068 ´ëÀü 2024 ´ëÀü¼­±¸ÀÇ»çȸ Çмú´ëȸ : 2024-07-05 0 9 2024-06-18
21067 °æºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ - Á¦3ȸ ¿¬¼ö°­Á : 2024-07-05 0 8 2024-06-18
21066 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø 125Áֳ⠱â³ä ±¹Á¦Çмú´ëȸ : 2024-07-05 0 4 2024-06-18
21065 ¼­¿ï ´ëÇÑÅ»ÀåÇÐȸ 18th Congress of the KHS & 2024 International Symposium(1ÀÏÂ÷) : 2024-07-05 0 5 2024-06-18
21064 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ (¿Â¶óÀÎ) 2024³â ÇϹݱâ ÀÇÇй°¸® Àü¹®±³À° 1 : 2024-07-05 0 3 2024-06-18
21063 °æ³² ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦111Â÷ ¿¬¼ö±³À° : 2024-07-04 0 11 2024-06-18
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 3 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 4 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷